Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer - Chemosensitivity test and a comparative study with doxorubicin

T. Nakashima, A. Masuda, G. Yano, Y. Maehara

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

抜粋

The chemosensitivities of 77 samples of human head and neck cancer were examined by in vitro succinate dehydrogenase inhibition (SDI) test. The tumor tissues obtained at biopsy specimens were exposed to doxorubicin (DXR) and pirarubicin (THP). The average decrease of the enzyme activity by THP was significantly greater than that by DXR. In 60 cases of squamous cell carcinomas, the chemosensitivity of poorly differentiated type tended to be higher compared to the well differentiated type. It is suggested from there results that THP is a more effective anticancer drug than DXR against human head and neck cancers. Clinically good responses were obtained in a systemic chemotherapy of such as head and neck adenoid cystic carcinomas by combining THP with other anticancer drugs such as CDDP (or CBDCA) and CPA.

元の言語英語
ページ(範囲)633-639
ページ数7
ジャーナルJapanese Journal of Cancer and Chemotherapy
21
発行部数5
出版物ステータス出版済み - 1 1 1994

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

フィンガープリント Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer - Chemosensitivity test and a comparative study with doxorubicin' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用